Briggs Morrison, President, Head of R&D at Syndax Pharmaceuticals Inc (SNDX), sold 208,346 shares at $18.29 ($3.6M) on 2022-04-04, disclosed to the SEC on 2022-04-05.
Open-market sale of $3.6M SNDX by President, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.44 | 6,000 | $105K | 2.9% |
| 2 | $17.44 | 6,000 | $105K | 2.9% |
| 3 | $17.44 | 24,500 | $427K | 11.7% |
| 4 | $17.44 | 24,500 | $427K | 11.7% |
| 5 | $17.46 | 70,545 | $1.2M | 33.8% |
| 6 | $17.46 | 70,545 |
| $1.2M |
| 33.8% |
| 7 | $18.29 | 3,128 | $57K | 1.6% |
| 8 | $18.29 | 3,128 | $57K | 1.6% |
| Total | $17.48 avg | 208,346 | $3.6M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |